Biomarkers /
SDHAF2
Overview
Succinate dehydrogenase complex assembly factor 2 (SDHAF2) is a gene that encodes a mitochondrial protein. Missense mutations, synonymous mutations, and frameshift insertions have been observed in cancers such as colon cancer, kidney cancer, and skin cancer.
SDHAF2 is altered in 0.37% of all cancers with breast invasive ductal carcinoma, lung adenocarcinoma, invasive breast carcinoma, colon adenocarcinoma, and breast invasive lobular carcinoma having the greatest prevalence of alterations [3].
The most common alterations in SDHAF2 are SDHAF2 Mutation (0.18%), SDHAF2 Amplification (0.14%), SDHAF2 Loss (0.04%), SDHAF2 S10L (0.02%), and SDHAF2 R154H (0.01%) [3].
Clinical Trials
Significance of SDHAF2 in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.